Introducing the new BA E-2100 Glycine ELISA
About Glycine
Glycine is an amino acid which is considered as the most important inhibitory neurotransmitter in the central nervous system, especially in the spinal cord, brainstem, and retina and plays a key role in metabolic regulation, anti-oxidative reactions, and neurological function.
The detection of glycine is indicated in a wide variety of diseases ranging from infarction, tumor, leukoencephalopathies, infection to gliosis. In addition studies show that Glycine may help to improve memory retrieval in individuals with a wide variety of sleep-depriving conditions, including jet lag and overwork.
As a nutrient Glycine has been used to: (1) prevent tissue injury; (2) enhance anti-oxidative capacity; (3) promote protein synthesis and wound healing; (4) improve immunity; and (5) treat metabolic disorders in obesity, diabetes, cardiovascular disease, ischemia-reperfusion injuries, cancers, and various inflammatory diseases.
The Glycine ELISA is a sensitive assay for the quantitative determination of Glycine in human urine samples and is intended for research use only.
Assay Characteristics
Common sample preparation. Derivatization in liquid phase (96-well-reaction plate). Immunoassay using 12x8 break apart wells microtiter plate (precoated). 6 standards. 2 controls; ready for use.
Sample Size: 20 μl urine
Standard Range: 0/2.5-2500 μg/mL
Sensitivity: 3.3 μg/mL
Assay Time: Sample preparation and derivatization 2.5 hours; ELISA overnight, 2 x 30 min2 x 30 min
| Substance | Cross Reactivity (%) |
Glycine |
100 |
D-Serin |
3.7 |
L-Cystine |
1.8 |
Beta-Alanin |
0.7 |
GABA |
0.8 |
L-Aspartic Acid |
< 0.1 |
L-Glutamate |
< 0.1 |
Taurine |
< 0.1 |